Gesche Schultek

Dr. Gesche Schultek


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2022 in Cancers
Verified
Journal Article
Open access
PDF file
GSGesche Schultek
Gesche Schultek
BGBernd Gerber
Bernd Gerber
TRToralf Reimer
Toralf Reimer
JSJohannes Stubert
Johannes Stubert
SHSteffi Hartmann
Steffi Hartmann
ASAngrit Stachs
Angrit Stachs
Background: Radiological underestimation of the actual tumor size is a relevant problem in reaching negative margins in ductal carcinoma in situ (DCIS) associated with microcalcifications in breast-conserving therapy (BCT). The aim of this study is to evaluate whether the radiological underestimation of tumor size has an influence on the histopathological margin status. Methods: Patients who underwent BCT with preoperatively diagnosed pure DCIS were included (pooled analysis of two trials). Multiple factors were analysed regarding radiological underestimation ≥10 mm. Radiological underestimation was defined as mammographic minus histological tumor size in mm. Results: Positive margins occurred in 75 of 189 patients. Radiological underestimation ≥10 mm was an independent influencing factor (OR 5.80; 95%CI 2.55–13.17; p < 0.001). A radiological underestimation was seen in 70 patients. The following parameters were statistically significant associated with underestimation: pleomorphic microcalcifications (OR 3.77; 95%CI 1.27–11.18), clustered distribution patterns (OR 4.26; 95%CI 2.25–8.07), and mammographic tumor sizes ≤20 mm (OR 7.47; 95%CI 3.49–15.99). Only a mammographic tumor size ≤20 mm was an independent risk factor (OR 6.49; 95%CI 2.30–18.26; p < 0.001). Grading, estrogen receptor status, and comedo necrosis did not influence the size estimation. Conclusion: Radiological underestimation is an independent risk factor for positive margins in BCT of DCIS associated with microcalcifications predominantly occurring in mammographic small tumors.

26 May 2021 in Cancers
Verified
Journal Article
Open access
PDF file
SHSteffi Hartmann
Steffi Hartmann
ASAngrit Stachs
Angrit Stachs
GSGesche Schultek
Gesche Schultek
BGBernd Gerber
Bernd Gerber
TRToralf Reimer
Toralf Reimer
Purpose: To assess the impact of the removal of the target lymph node (TLN) on therapy after the completion of primary systemic therapy (PST) in initially node-positive breast cancer patients. Methods: Pooled data analysis of participants of the prospective CLIP- and TATTOO-study at the University of Rostock was performed. Results: A total of 75 patients were included; 63 of them (84.0%) converted to clinically node-negative after PST. Both TLN and sentinel lymph node (SLN) were identified in 41 patients (51.2%). In five out of 63 patients (7.9%), the TLN was metastatic after PST and the SLN was either tumor-free or not detected. Axillary lymph node dissection (ALND) was conducted in all five patients. In one patient, systemic therapy recommendation was influenced by the TLN; adjuvant radiotherapy was influenced by the TLN in zero patients. For patients with fewer than three removed SLNs, the FNR was 28.6% for the SLN biopsy alone and 7.1% for targeted axillary dissection (TAD). Conclusions: Removal of the TLN in addition to the SLN after PST has only minimal impact on the type of adjuvant systemic therapy and radiotherapy. However, the extent of axillary surgery was relevantly affected and FNR was improved by TAD.

13 August 2025 in European Journal of Surgical Oncology
Verified
Journal Article
Open access
GSGesche Schultek
Gesche Schultek
BGBernd Gerber
Bernd Gerber
SHSteffi Hartmann
Steffi Hartmann
TRToralf Reimer
Toralf Reimer
JSJohannes Stubert
Johannes Stubert
ASAngrit Stachs
Angrit Stachs
A stereotactic vacuum-assisted breast biopsy (VABB) is used to assess non-palpable breast lesions. The current study aims to identify possible influencing factors for clip migration and the impact of clip migration on surgery. In a retrospective study, clip migration in post-biopsy mammograms was evaluated (using a cut-off of ≥10 mm vs. <10 mm). Clip migration of ≥10 mm occurred in 35 patients (20.5 %). Breast density, type of clip, and bleeding did not influence the risk of clip migration. Clip migration along the access path (z-axis) and lower breast thickness were the only significant factors in relevant clip migration. Surgery was performed on 57 patients (33.3 %), including seven cases of clip migration ≥10 mm. A wire-guided localization was possible in all cases of pre-invasive or invasive lesions due to residual microcalcifications. Clip migration immediately after a VABB is common but has little negative impact on subsequent procedures.

21 August 2023 in Die Gynäkologie
Verified
Journal Article
Closed access
PDF file
GSGesche Schultek
Gesche Schultek
BGBernd Gerber
Bernd Gerber
TRToralf Reimer
Toralf Reimer
ASAngrit Stachs
Angrit Stachs
SHSteffi Hartmann
Steffi Hartmann